The trademark application SEQURE DX was filed by SeQure Dx, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on November 30, 2022, and it was registered by office on March 9, 2023 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 1 with Kits comprised of assays for use in connection with genomic testing, sequencing, and analysis for scientific and research purposes.
The mark was filed in class 5 with Kits comprised of assays for use in connection with genomic testing, sequencing, and analysis for medical purposes.
The mark was filed in class 42 with following description of goods:
Research and development services in the fields of gene editing and genomic profiling
Providing scientific information in the fields of gene editing and genomic profiling
Conducting clinical trials for others in the fields of gene editing and profiling.
The mark was filed in class 44 with Medical diagnostic testing of biological material and medical analysis of data relating to the treatment of persons for third parties in the fields of gene editing and genomic profiling and providing medical information in the fields of gene editing and genomic profiling..